Head and Neck Squamous Cell Carcinoma (HNSCC) Completed Phase 2 Trials for DB11666 (Buparlisib)

Also known as: Head and Neck Squamous Cell Carcinoma

IndicationStatusPhase
DBCOND0043665 (Head and Neck Squamous Cell Carcinoma (HNSCC))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs